Unani Concepts for Maintaining Mobility in Later Life

Abstract

Mobility impairment is a significant concern in geriatric populations, impacting quality of life, independence, and overall health outcomes. Unani medicine, a traditional system rooted in Greco-Arabic concepts, offers unique frameworks and therapies aimed at preserving mobility in later life. This review synthesizes classical Unani principles, recent scientific evidence, clinical applications, and guideline-based recommendations, providing a comprehensive resource for healthcare professionals interested in integrative approaches to geriatric mobility. The article explores the epidemiology of mobility decline, underlying pathophysiological mechanisms, risk factors, clinical manifestations, diagnostic strategies, and both traditional and emerging therapeutic interventions within a Unani paradigm. Practical implications and the future scope of Unani contributions to geriatric mobility are discussed in the context of modern clinical practice.

Introduction

Maintaining mobility is a cornerstone of healthy aging, directly associated with autonomy, social participation, and prevention of secondary complications such as falls, frailty, and institutionalization. Conventional medicine focuses on musculoskeletal health, neurological integrity, and comorbid management. However, integration with traditional systems such as Unani medicine may offer novel preventive and therapeutic perspectives. Unani medicine conceptualizes health as a balance of humors (Akhlat), temperament (Mizaj), and organ system integrity, with movement and mobility reflecting the harmony of bodily elements. This review aims to elucidate Unani concepts relevant to mobility, align them with contemporary clinical insights, and explore their translational relevance for healthcare professionals managing geriatric patients.

Epidemiology / Disease Burden

Globally, the prevalence of mobility limitation rises steadily with advancing age, affecting approximately 30-50% of individuals over 65 years, according to WHO and recent epidemiological surveys. Mobility impairment is associated with increased morbidity, mortality, hospitalization, and healthcare costs. In many regions, limited access to rehabilitative care and social support exacerbates the disease burden. Unani medicine, with its emphasis on preventive care and holistic management, has been practiced for centuries in regions with high geriatric populations, including South Asia and the Middle East, potentially providing scalable models for reducing mobility-related disability.

Pathophysiology

From a Unani perspective, mobility is governed by the integrity of organs (Aaza), the strength of faculties (Quwa), and the optimal state of humors (Akhlat). Age-related decline is attributed to the predominance of cold and dry qualities (Barid wa Yabis Mizaj), leading to 'Su-e-Mizaj' (deranged temperament) of the musculoskeletal and nervous systems. Modern pathophysiology aligns with these concepts by recognizing sarcopenia, osteoarthritis, peripheral neuropathy, and vascular insufficiency as major contributors to mobility loss. Chronic inflammation, oxidative stress, hormonal changes, and microvascular compromise are underlying mechanisms that resonate with Unani's understanding of humor imbalance and temperamental shifts in aging.

Risk Factors

Key risk factors for mobility decline identified in both scientific literature and Unani doctrine include advancing age, chronic diseases (e.g., diabetes, hypertension), sedentary lifestyle, nutritional deficiencies, obesity, and prior musculoskeletal injuries. Unani texts emphasize dietary indiscretions, poor sleep, excess exposure to cold and dryness, and neglect of physical activity as contributors to deranged temperament and functional loss. Gender, genetic predisposition, socioeconomic status, and environmental factors also modulate risk, necessitating a personalized approach in assessment and intervention.

Clinical Features

Mobility impairment manifests as gait disturbance, reduced walking speed, difficulty rising from a chair, imbalance, and increased fall risk. In Unani clinical evaluation, these are contextualized through assessment of Mizaj (temperament), Quwa (faculties), and Tabiat (innate nature). Additional signs include generalized weakness (Zauf), joint stiffness (Tashannuj), tremors, and fatigue. Comprehensive history-taking and physical examination are integral to identifying early functional loss and guiding intervention.

Diagnosis

Diagnosis in Unani medicine involves a multi-layered approach, incorporating temperament analysis, pulse examination (Nabz), and detailed musculoskeletal and neurological assessment. Contemporary diagnostics employ validated tools such as the Timed Up and Go (TUG) test, gait speed measurement, grip strength, and imaging modalities (X-rays, MRI) to assess structural and functional deficits. Laboratory tests may evaluate inflammatory markers, hormonal status, and nutritional profiles. Integrating Unani diagnostic frameworks with modern tools enables a holistic appraisal of mobility-related dysfunction.

Treatment & Management

Unani therapeutics prioritize restoring balance of humors, optimizing temperament, and strengthening organ faculties. Key interventions include: (1) Regimenal therapy (Ilaj-bil-Tadbeer): Physical activity, massage (Dalk), cupping (Hijama), steam baths (Hammam), and tailored exercise protocols designed to counteract cold and dry derangements; (2) Pharmacotherapy (Ilaj-bil-Dawa): Use of herbal formulations such as Roghan-e-Badam, Majoon Suranjan, and decoctions containing Withania somnifera and Boswellia serrata for anti-inflammatory, nutritive, and rejuvenating effects; (3) Dietotherapy (Ilaj-bil-Ghiza): Emphasis on nutrient-rich, warm, and moist foods, adequate hydration, and seasonal dietary modification. Patient education, fall prevention, orthopedic aids, and multidisciplinary rehabilitation are integral to comprehensive management.

Recent Advances / Emerging Therapies

Recent research underscores the role of Unani herbal extracts in reducing inflammation, enhancing muscle strength, and improving joint flexibility, supported by in vitro and clinical studies. Standardization of Unani formulations, integration with physiotherapy, and development of evidence-based protocols are ongoing areas of innovation. Digital health interventions, teleconsultation, and mobile applications for regimenal therapy adherence are emerging trends. Clinical trials examining the efficacy of Unani medicine as adjunctive therapy in osteoarthritis, sarcopenia, and neuropathic conditions are expanding the evidence base for its inclusion in geriatric mobility management.

Guideline Recommendations

Leading Unani institutes and integrative medicine guidelines advocate for early assessment of temperament and musculoskeletal health in older adults, regular implementation of regimenal therapies, and individualized pharmacological interventions. The National Unani Pharmacopoeia and WHO Traditional Medicine Strategy emphasize quality assurance, safety monitoring, and interdisciplinary collaboration. For clinicians, integrating Unani principles with standard geriatric assessment enables a more nuanced and culturally sensitive approach to mobility preservation.

Conclusion

Unani medicine provides a rich, mechanism-based framework for understanding and managing mobility challenges in later life. Its holistic approach, grounded in temperament balance and organ system integrity, complements modern clinical strategies and offers promising avenues for prevention, early intervention, and rehabilitation. Continued research, standardization, and cross-disciplinary collaboration are essential to fully harness the potential of Unani concepts in improving mobility outcomes for the aging population.